Philippe Mavier
Impact in
- Hepatology top 1%
- Liver physiology and pathology
- Liver Disease and Transplantation
- Hepatitis C virus research
- Pharmacology top 1%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
Papers in
- Hepatology 42
- Liver physiology and pathology 30
- Liver Disease and Transplantation 5
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Pharmacology 13
- Drug-Induced Hepatotoxicity and Protection 7
- Pharmacogenetics and Drug Metabolism 7
- Co-authors
- Anne-Marie Préaux (26 shared papers)Daniel Dhumeaux (31 shared papers)Ariane Mallat (17 shared papers)Jean Rosenbaum (16 shared papers)Élie Serge Zafrani (14 shared papers)Yannick Laperche (9 shared papers)Elie‐Serge Zafrani (9 shared papers)Sylvie Blazejewski (4 shared papers)
In The Last Decade
Philippe Mavier
65 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 97
- Hepatology 1k
- Pharmacology 278
- Pathology and Forensic Medicine 201
- Immunology 161
- Cancer Research 97
Countries citing papers authored by Philippe Mavier
This map shows the geographic impact of Philippe Mavier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Mavier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Mavier more than expected).
Fields of papers citing papers by Philippe Mavier
This network shows the impact of papers produced by Philippe Mavier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Mavier. The network helps show where Philippe Mavier may publish in the future.
Co-authors
The 25 scholars most cited alongside Philippe Mavier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 158 | |
| 2 | 1999 | 120 | |
| 3 | Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor. | 1993 | 118 |
| 4 | 1990 | 110 | |
| 5 | 1995 | 102 | |
| 6 | 1993 | 96 | |
| 7 | 1996 | 94 | |
| 8 | 1998 | 89 | |
| 9 | 1988 | 87 | |
| 10 | 1977 | 69 | |
| 11 | 2002 | 69 | |
| 12 | 1995 | 68 | |
| 13 | 2004 | 68 | |
| 14 | 2006 | 68 | |
| 15 | 1986 | 67 | |
| 16 | 1997 | 65 | |
| 17 | 1977 | 64 | |
| 18 | 1976 | 61 | |
| 19 | 2011 | 61 | |
| 20 | 1984 | 60 |
About Philippe Mavier
Philippe Mavier is a scholar working on Hepatology, Pharmacology, Immunology, Pathology and Forensic Medicine and Molecular Biology, having authored 68 papers that have together received 2.5k indexed citations. Recurring topics across this work include Liver physiology and pathology (30 papers), Drug-Induced Hepatotoxicity and Protection (7 papers), Pharmacogenetics and Drug Metabolism (7 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers), Liver Disease and Transplantation (5 papers), Alcohol Consumption and Health Effects (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Hepatology (1k citations), Pharmacology (278 citations), Pathology and Forensic Medicine (201 citations), Immunology (161 citations) and Cancer Research (97 citations). Philippe Mavier has collaborated with scholars based in France, Canada and Japan. Frequent co-authors include Anne-Marie Préaux, Daniel Dhumeaux, Ariane Mallat, Jean Rosenbaum, Élie Serge Zafrani, Yannick Laperche, Elie‐Serge Zafrani, Sylvie Blazejewski, Dominique Couchie and Jean‐Gil Joly. Their work appears in journals such as Hepatology, Journal of Hepatology, Biochemical Pharmacology, Gastroenterology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.